Biogen receives exclusive rights to commercialize zorevunersen outside U.S., Europe, and Japan.

Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat Dravet ...

Biogen will receive rights to commercialize zorevunersen outside the US, Canada, and Mexico, paying $165 million upfront and other milestone payments.

Hi-Tech Pipes Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 2,048.95 Crore) operating in Metals - Ferrous sector. Hi-Tech Pipes Ltd. key Products/Revenue ...

Garware Hi-Tech Films Ltd., incorporated in the year 1957, is a Small Cap company (having a market cap of Rs 8,848.17 Crore) operating in Packaging sector. Garware Hi-Tech Films Ltd. key ...